Alector (ALEC) Cash from Operations (2018 - 2026)
Alector (ALEC) reported Cash from Operations of 49813000.0 for Q1 2026, up 18.05% year-over-year from 42197309.92 in Q1 2025, and down 19.48% quarter-over-quarter from 41691000.0 in Q4 2025.
Alector (ALEC) Cash from Operations (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash from Operations data on file, last reported at 49813000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 49813000.0, up 18.05% year-over-year; the trailing twelve-month figure through Mar 2026 was 173061000.0 (up 24.54% YoY), and the FY2025 annual result was 184031000.0, up 19.95% from the prior year.
- Cash from Operations declined to 49813000.0 in Q1 2026 per ALEC's latest filing, from 41691000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 135091000.0 in Q1 2022 and troughed at 62797000.0 in Q2 2024.
- A 5-year average of 39308235.29 and a median of 49046000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations soared 356.37% in 2022, then plunged 135.94% in 2023.
- A 5-year view of Cash from Operations shows it stood at 48925000.0 in 2022, then gained by 5.84% to 46070000.0 in 2023, then slipped by 19.44% to 55028000.0 in 2024, then climbed by 24.24% to 41691000.0 in 2025, then dropped by 19.48% to 49813000.0 in 2026.
- Business Quant data shows ALEC's Cash from Operations at 49813000.0 in Q1 2026, 41691000.0 in Q4 2025, and 32511000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | -49.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.81 Mn |
| Mar 31, 2026 | -49.81 Mn |
| Dec 31, 2025 | -41.69 Mn |
| Dec 31, 2025 | -41.69 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Jun 30, 2025 | -49.05 Mn |
| Jun 30, 2025 | -49.05 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Dec 31, 2024 | -55.03 Mn |
| Dec 31, 2024 | -55.03 Mn |
| Sep 30, 2024 | -50.73 Mn |
| Sep 30, 2024 | -50.73 Mn |
| Jun 30, 2024 | -62.80 Mn |
| Jun 30, 2024 | -62.80 Mn |
| Mar 31, 2024 | -61.35 Mn |
| Mar 31, 2024 | -61.35 Mn |
| Dec 31, 2023 | -46.07 Mn |
| Dec 31, 2023 | -46.07 Mn |